Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 25 studies | 24% ± 7% | |
CD16-positive, CD56-dim natural killer cell, human | 13 studies | 33% ± 10% | |
conventional dendritic cell | 11 studies | 27% ± 15% | |
CD16-negative, CD56-bright natural killer cell, human | 11 studies | 27% ± 6% | |
dendritic cell | 10 studies | 30% ± 13% | |
classical monocyte | 8 studies | 24% ± 9% | |
mature NK T cell | 7 studies | 24% ± 6% | |
neutrophil | 5 studies | 25% ± 7% | |
CD8-positive, alpha-beta T cell | 5 studies | 20% ± 5% | |
gamma-delta T cell | 5 studies | 20% ± 3% | |
effector memory CD8-positive, alpha-beta T cell | 4 studies | 17% ± 2% | |
macrophage | 4 studies | 24% ± 7% | |
CD8-positive, alpha-beta memory T cell | 4 studies | 17% ± 2% | |
myeloid cell | 3 studies | 21% ± 2% | |
monocyte-derived dendritic cell | 3 studies | 28% ± 3% |
Insufficient scRNA-seq data for expression of ADAM8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 3571.72 | 578 / 578 | 94% | 36.20 | 1088 / 1155 |
bladder | 90% | 992.38 | 19 / 21 | 91% | 38.98 | 461 / 504 |
ovary | 92% | 466.22 | 165 / 180 | 90% | 20.37 | 388 / 430 |
pancreas | 84% | 406.24 | 277 / 328 | 95% | 58.52 | 169 / 178 |
uterus | 89% | 463.24 | 151 / 170 | 88% | 37.74 | 403 / 459 |
breast | 83% | 464.18 | 379 / 459 | 87% | 18.16 | 977 / 1118 |
stomach | 88% | 560.57 | 315 / 359 | 81% | 18.15 | 232 / 286 |
intestine | 79% | 742.21 | 767 / 966 | 78% | 17.30 | 409 / 527 |
esophagus | 62% | 308.39 | 892 / 1445 | 89% | 24.80 | 162 / 183 |
thymus | 98% | 703.79 | 641 / 653 | 45% | 6.17 | 272 / 605 |
kidney | 93% | 725.43 | 83 / 89 | 50% | 6.10 | 449 / 901 |
prostate | 95% | 800.37 | 233 / 245 | 46% | 3.80 | 231 / 502 |
skin | 64% | 329.61 | 1152 / 1809 | 63% | 12.17 | 297 / 472 |
liver | 100% | 720.71 | 225 / 226 | 24% | 4.20 | 98 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 57.42 | 29 / 29 |
peripheral blood | 100% | 25820.33 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 7981.38 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 39.07 | 44 / 45 |
brain | 61% | 258.87 | 1610 / 2642 | 33% | 3.99 | 234 / 705 |
adipose | 90% | 734.42 | 1080 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 72% | 323.93 | 186 / 258 | 13% | 1.49 | 31 / 230 |
blood vessel | 67% | 531.31 | 896 / 1335 | 0% | 0 | 0 / 0 |
heart | 33% | 149.48 | 280 / 861 | 0% | 0 | 0 / 0 |
muscle | 8% | 26.48 | 63 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.28 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001525 | Biological process | angiogenesis |
GO_0006954 | Biological process | inflammatory response |
GO_0051044 | Biological process | positive regulation of membrane protein ectodomain proteolysis |
GO_0022407 | Biological process | regulation of cell-cell adhesion |
GO_0070245 | Biological process | positive regulation of thymocyte apoptotic process |
GO_0007249 | Biological process | canonical NF-kappaB signal transduction |
GO_2000309 | Biological process | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production |
GO_0002523 | Biological process | leukocyte migration involved in inflammatory response |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0002693 | Biological process | positive regulation of cellular extravasation |
GO_0045089 | Biological process | positive regulation of innate immune response |
GO_0023061 | Biological process | signal release |
GO_0050714 | Biological process | positive regulation of protein secretion |
GO_0048247 | Biological process | lymphocyte chemotaxis |
GO_0006508 | Biological process | proteolysis |
GO_2000391 | Biological process | positive regulation of neutrophil extravasation |
GO_0010954 | Biological process | positive regulation of protein processing |
GO_0002675 | Biological process | positive regulation of acute inflammatory response |
GO_0010718 | Biological process | positive regulation of epithelial to mesenchymal transition |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0033089 | Biological process | positive regulation of T cell differentiation in thymus |
GO_0000902 | Biological process | cell morphogenesis |
GO_2000418 | Biological process | positive regulation of eosinophil migration |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_2000415 | Biological process | positive regulation of fibronectin-dependent thymocyte migration |
GO_0045780 | Biological process | positive regulation of bone resorption |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0035579 | Cellular component | specific granule membrane |
GO_0071133 | Cellular component | alpha9-beta1 integrin-ADAM8 complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0002102 | Cellular component | podosome |
GO_0070820 | Cellular component | tertiary granule |
GO_0032127 | Cellular component | dense core granule membrane |
GO_0042581 | Cellular component | specific granule |
GO_0032010 | Cellular component | phagolysosome |
GO_0009986 | Cellular component | cell surface |
GO_0070821 | Cellular component | tertiary granule membrane |
GO_0101003 | Cellular component | ficolin-1-rich granule membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0008237 | Molecular function | metallopeptidase activity |
GO_0034987 | Molecular function | immunoglobulin receptor binding |
GO_0032813 | Molecular function | tumor necrosis factor receptor superfamily binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0050839 | Molecular function | cell adhesion molecule binding |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | ADAM8 |
Protein name | ADAM8 protein (cDNA, FLJ93272, highly similar to Homo sapiens a disintegrin and metalloproteinase domain 8 (ADAM8),mRNA) Disintegrin and metalloproteinase domain-containing protein 8 (ADAM 8) (EC 3.4.24.-) (Cell surface antigen MS2) (CD antigen CD156a) ADAM metallopeptidase domain 8 |
Synonyms | MS2 |
Description | FUNCTION: Possible involvement in extravasation of leukocytes. |
Accessions | Q14C66 H0YKZ1 ENST00000485491.6 [P78325-2] ENST00000445355.8 [P78325-1] ENST00000415217.7 [P78325-3] P78325 H0YMT6 ENST00000560135.5 ENST00000486609.1 |